The Effect of Mandala Coloring on Quality of Life in Cancer Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmine TARLABELEN KARAYTUĞ
About this trial
This study aims to determine the effect of mandala coloring on the quality of life in cancer patients. Conducting a quasi-experimental design with a pretest-posttest control group, the study will involve a total of 76 cancer patients hospitalized in an oncology ward. Participants will be assigned to either the experimental (mandala) group or the control group. At the baseline, data will be collected face-to-face using a Patient Information Form and the EORTC QLQ-C30 Version 3.0 Quality of Life Scale. Patients in the experimental group will be provided with a mandala coloring book and colored pencils, and they will practice mandala coloring for 30 minutes, at least twice a week, over a 3-week period. The control group will receive routine clinical care with no intervention. After 3 weeks, the EORTC QLQ-C30 scale will be re-administered to both groups to evaluate and compare changes in their quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with cancer
Aged 18 years and older
Voluntarily willing to participate in the study
Able to hold and use a pencil for coloring
Disqualifiers
Refusing to participate or withdraws consent before the study begins
Unable to comply regularly with the scheduled mandala coloring program
Incapable of using a pencil due to physical or cognitive impairments
Trial design
Design model
Parallel
Treatments tested in this trial
Mandala Coloring
BehavioralPatients in the experimental group will be provided with a mandala coloring book and a set of 12 colored pencils. They will be requested to practice mandala coloring in a quiet, distraction-free environment for 30 minutes, at least twice a week, for a total duration of 3 weeks. The intervention will be conducted in addition to routine clinical care.
Treatment groups
76 Participants
are divided into 2 treatment groupsGroup A: Mandala Coloring InterventionExperimental treatment 1 intervention
Group B: Standard CareNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Quality of Life Score via EORTC QLQ-C30
Quality of life will be evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) Version 3.0. The questionnaire includes 30 items. All raw scores are linearly transformed into a standard scale ranging from 0 to 100. For the global health and functional scales, a higher score indicates a better quality of life. For the symptom scales, a higher score indicates a worse outcome.
Time frame
Baseline and 3 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Emine TARLABELEN KARAYTUĞ
Lead sponsor
Aydin Adnan Menderes University
Sponsor institution
The Scientific and Technological Research Council of Turkey
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: